Mode
Text Size
Log in / Sign up

YAP and TAZ Overexpression Predicts Worse Survival in Oral Squamous Cell CarcinomaHippo Pathway Markers Linked to Oral Cancer Survival Rates

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider YAP and TAZ as potential prognostic biomarkers in OSCC, but interpret pooled estimates cautiously due to heterogeneity.

This meta-analysis pooled data from 17 studies to evaluate the prognostic significance of immunohistochemical expression of the Hippo pathway effectors YAP and TAZ in patients with oral squamous cell carcinoma. The analysis included 1194 patients and focused on overall survival as the primary outcome, with secondary assessments of clinicopathological features including advanced clinical stage, lymph node metastasis, and histological differentiation.

Pooled results showed that YAP overexpression was associated with worse overall survival (hazard ratio, 1.918; 95% confidence interval, 1.036 to 3.549; p = 0.038). TAZ overexpression was associated with poorer overall survival (hazard ratio, 2.845; 95% confidence interval, 1.682 to 4.811; p < 0.001). Predominantly nuclear expression of YAP and TAZ was associated with advanced clinical stage, lymph node metastasis, and poorer histological differentiation, though effect sizes and p-values for these clinicopathological associations were not reported.

The authors note substantial between-study heterogeneity and methodological heterogeneity as key limitations. Adverse events, follow-up duration, and funding or conflicts of interest were not reported. The association is not causal, and the methodological heterogeneity warrants cautious interpretation of the pooled estimates.

These findings suggest that YAP and TAZ may have prognostic value in oral squamous cell carcinoma, but the heterogeneity and lack of standardized cutoffs limit immediate clinical application. Further validation is needed before these biomarkers can be used to guide management.

How this fits prior evidence

This meta-analysis extends prior coverage of prognostic and risk factors in oral squamous cell carcinoma. Previous findings established perineural invasion as a strong independent predictor of poor survival and increased local recurrence in OSCC, and identified distinct microbial taxa and functional pathways associated with OSCC. The current analysis adds YAP and TAZ as potential prognostic biomarkers, with pooled hazard ratios of 1.918 for YAP and 2.845 for TAZ. Unlike the SMMI framework, which is a conceptual model for risk stratification, this meta-analysis provides pooled quantitative estimates, though substantial heterogeneity limits certainty.

Researchers analyzed data from 1,194 patients with oral squamous cell carcinoma to look at the Hippo pathway. They specifically looked at two proteins called YAP and TAZ. The study found that when these proteins were overexpressed, patients had a worse overall survival rate. Specifically, TAZ overexpression was linked to a higher risk of poorer outcomes compared to the control group.

In addition to survival rates, the study looked at other clinical features. The researchers found that when YAP and TAZ were primarily located in the cell nucleus, it was linked to more advanced stages of the disease, the spread of cancer to lymph nodes, and poorer histological differentiation.

Because this was a meta-analysis of 17 different studies, there was a lot of variation in how the studies were conducted. These differences mean the results should be interpreted with caution. While these markers show a link to how the disease progresses, they are currently used as indicators rather than a direct cause of the condition.

What this means for you:
High levels of YAP and TAZ proteins are linked to poorer outcomes in some oral squamous cell carcinoma cases.

Common questions

What are YAP and TAZ in oral cancer?

YAP and TAZ are proteins within the Hippo pathway. This study looked at how their expression affects patients with oral squamous cell carcinoma. The researchers found that higher levels of these proteins, especially when located in the cell nucleus, were linked to more advanced stages of the disease and poorer survival rates.

How does the study link these proteins to cancer progression?

The study found that the presence of these proteins was linked to several clinical features. Specifically, nuclear expression of YAP and TAZ was associated with lymph node metastasis and poorer histological differentiation. These findings suggest the proteins may have prognostic value in identifying how the cancer behaves.

How reliable are these findings for patients?

The results come from a meta-analysis of 17 studies involving 1,194 patients. However, because the studies were very different from one another, the results should be interpreted with caution. These markers show a link to outcomes, but they do not prove a direct cause. You should talk to your doctor about what this means for your specific case.

Study Details

Study typeMeta analysis
Sample sizen = 1,194
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
Background: This systematic review and meta-analysis evaluated the prognostic value of Hippo signaling pathway biomarkers in oral squamous cell carcinoma. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, electronic database searches identified 17 eligible studies involving 1,194 patients. Associations between the immunohistochemical expression of Hippo pathway effectors, primarily YAP and TAZ, and clinicopathological characteristics were assessed. Meta-analyses using random-effects models estimated pooled hazard ratios for overall survival. Results: Predominantly nuclear expression of YAP and TAZ was consistently associated with adverse clinicopathological features, including advanced clinical stage, lymph node metastasis, and poorer histological differentiation. Meta-analysis demonstrated that YAP overexpression was associated with worse overall survival (hazard ratio, 1.918; 95% confidence interval, 1.036 to 3.549; p = 0.038). TAZ overexpression was similarly associated with poorer overall survival (hazard ratio, 2.845; 95% confidence interval, 1.682 to 4.811; p < 0.001). Although substantial between-study heterogeneity was observed, the direction of the prognostic association remained consistent across studies. Conclusions: Increased nuclear expression of YAP and TAZ is consistently associated with more aggressive disease and poorer overall survival in oral squamous cell carcinoma. These findings support the prognostic value of Hippo pathway biomarkers, although methodological heterogeneity warrants cautious interpretation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.